Skip to content

PROF. DR. B. SCHMELZER

Active
Private limited companyfounded 201312 yrs activeRooibos 4, 2160 Wommelgem, BelgiumKBO/BCE: BE 0543.435.669

PROF. DR. B. SCHMELZER has been active since 2013 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €196k and a net result of €61k. Equity remains stable across the filed fiscal years (±2.4% per year). Its solvency ranks better than 65% of 16426 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).

Checked score

Score 2025
97 / 100
Excellent
The score weighs solvency, liquidity and profitability. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability99▲+9
Solvency100=
Growth78=
Track record100
Bankruptcy probability, 12 months
0.1% Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €19k at 30 days acceptable
Liquidity ample (current ratio 4.44 against 4.78 in 2024; short-term debt: 22.4% and cash: 88.7% of total assets), and 22.8% of the assets are financed with debt.
Credit advice for your own amount and term

Signals

Six signals. The signal on the left, the evidence on the right.
lowers riskneutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Sector 86
lower
← fewer bankruptcies more bankruptcies →
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025
Solvency, return and age of the figures
Solvency
77.2%
Return on assets
23.9%
Age of the figures
9 mo
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation date
Age against the risk zone
elevated failure risk from 2 to 8 years 12 years 0 20 y
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 23-07-2026, 8 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
8 d early
2024
19 d late
2023
37 d early
2022
34 d early
2021
38 d early
2020
44 d early
2019
28 d early
← before the deadline after the deadline →
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven months
Position in the running window
18-09-2026 today31-12-2026 close31-07-2027 deadline
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage

Financials · fiscal year 2025, micro schema

Equity
€196k▼ 40.4%
2024 · €330k
2018: €166k 2019: €250k 2020: €316k 2021: €334k 2022: €328k 2023: €344k 2024: €330k
2018 → 2025
Total assets
€254k▼ 39.0%
2024 · €417k
2018: €251k 2019: €289k 2020: €347k 2021: €397k 2022: €394k 2023: €374k 2024: €417k
2018 → 2025
Net result
€61k▼ 13.2%
2024 · €70k
2018: €30k 2019: €84k 2020: €66k 2021: €73k 2022: €54k 2023: €45k 2024: €70k
2018 → 2025
Working capital
€196k▼ 40.2%
2024 · €327k
2018: €154k 2019: €241k 2020: €304k 2021: €322k 2022: €323k 2023: €339k 2024: €327k
2018 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise ▼ fall
Line20212022202320242025Trend
Equity€334k-€328k▼ 1.7%€344k▲ 4.7%€330k▼ 4.1%€196k▼ 40.4%
Operating result€113k-€75k▼ 33.4%€77k▲ 2.1%€94k▲ 22.0%€90k▼ 4.4%
Net result€73k-€54k▼ 25.9%€45k▼ 17.1%€70k▲ 55.2%€61k▼ 13.2%
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
€0€50k€100kOperating result 2021: €113k€113kNet result 2021: €73k€73kOperating result 2022: €75k€75kNet result 2022: €54k€54kOperating result 2023: €77k€77kNet result 2023: €45k€45kOperating result 2024: €94k€94kNet result 2024: €70k€70kOperating result 2025: €90k€90kNet result 2025: €61k€61k20212022202320242025
The operating result falls in 2025; 2025 is 4% below 2024.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €254k
Fixed assets €2k▼ 39.4%
Current assets €253k▼ 39.0%
Equity and liabilities €254k
Equity €196k▼ 40.4%
Debt €58k▼ 33.5%
The debt ratio rises from 20.9% to 22.8%. Equity and debt are lower.
Key figures and ratios
2025 value · change against 2024
EBITDA
€91k
2024 · €96k
Cash flow
€62k
2024 · €72k
Solvency
77.2%
2024 · 79.1%
Current ratio
4.44
2024 · 4.78
Quick ratio
4.44
2024 · 4.78
Debt / equity
0.29
2024 · 0.26
ROE
31.0%
2024 · 21.2%
ROA
23.9%
2024 · 16.8%
Interest coverage
86.34
2024 · 59.55
Debt
€58k
2024 · €87k
Debt ≤ 1 year
€57k
2024 · €87k
Income taxes
€30k
2024 · €23k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2025 against 2024
Balance sheet Code20242025
Assets
Total assets20/58€417k€254k
Fixed assets21/28€3k€2k
Tangible fixed assets22/27€3k€2k
Plant, machinery and equipment23€868€96
Other tangible fixed assets26€2k€2k
Current assets29/58€414k€253k
Amounts receivable within one year40/41€24k€24k
Trade receivables40€10k€18k
Other amounts receivable41€14k€7k
Cash at bank and in hand54/58€388k€226k
Deferred charges and accrued income490/1€3k€3k
Equity and liabilities
Total equity and liabilities10/49€417k€254k
Equity10/15€330k€196k
Contributions10/11€19k€19k=
Reserves13€311k€178k
Non-distributable reserves130/1€2k€2k=
Reserves not available under the articles1311€2k€2k=
Distributable reserves133€309k€176k
Amounts payable17/49€87k€58k
Amounts payable within one year42/48€87k€57k
Trade debts44€2k€2k
Suppliers440/4€2k€2k
Taxes, remuneration and social security45€4k€4k
Taxes450/3€4k€4k
Other amounts payable47/48€80k€51k
Accrued charges and deferred income492/3€549€1k
Income statement Code20242025
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€2k€1k
Other operating charges640/8€1k€1k
Gross operating margin9900€97k€92k
Operating profit (loss)9901€94k€90k
Financial income75/76B€628€2k
Recurring financial income75€628€2k
Financial charges65/66B€2k€1k
Recurring financial charges65€2k€1k
Profit (loss) for the period before taxes9903€93k€90k
Income taxes67/77€23k€30k
Profit (loss) for the period9904€70k€61k
Profit (loss) for the period to be appropriated9905€70k€61k
Appropriation of the result
Profit (loss) to be appropriated9906€70k€61k
Transfer from equity791/2€84k€194k
Transfer to equity691/2€70k€61k
To other reserves6921€70k€61k
Profit to be distributed694/7€84k€194k
Return on contributions (dividend)694€84k€194k

The notes to these accounts (5 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Download as CSV

Timeline · acts, filings and financial milestones

Next filing, fiscal year 2026, expected by 31-07-2027
2026
23-07
NBB filing Annual accounts filed
fiscal year 2025 · micro schema
2025
19-08
NBB filing Annual accounts filed
fiscal year 2024 · micro schema · 19 days late
2024
24-06
NBB filing Annual accounts filed
fiscal year 2023 · micro schema
2023
27-06
NBB filing Annual accounts filed
fiscal year 2022 · micro schema
2022
23-06
NBB filing Annual accounts filed
fiscal year 2021 · micro schema
2021
17-06
NBB filing Annual accounts filed
fiscal year 2020 · micro schema
2020
03-07
NBB filing Annual accounts filed
fiscal year 2019 · micro schema
2019
31-12
Financial Highest result since 2018net €84k ▲183%
Operating result €115k, net result €84k, both a record.
31-12
Financial Liquidity triplescurrent ratio 7.19
Current ratio from 2.81 to 7.19; short-term debt falls from €85k to €39k.
31-12
Financial Equity above €200kEq €250k ▲50.7%
2 profitable years in a row build equity to €250k.
18-06
NBB filing Annual accounts filed
fiscal year 2018 · micro schema
2018
29-06
NBB filing Annual accounts filed
fiscal year 2017 · micro schema
2017
11-07
NBB filing Annual accounts filed
fiscal year 2016 · micro schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.

Directors · office · real estate

Directors
2 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Wommelgem · 1 establishment unit since 2013
establishment The establishment unit on the map
Cannot be placed on the map

This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.

Rooibos 42160 Wommelgem
Ground area
779 m²
Building footprint
182 m²
Volume, LiDAR
1,215 m³
Parcel 11052D0002/00A004, Flanders · tallest building 10.6 m, ±2 floors. Linked by address, not a title deed.
1 establishment unit
PROF. DR. B. SCHMELZER
Rooibos 4, 2160 WommelgemSpecialist medical practice
since 20132.225.014.011
1 parcel
Flanders 1 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
11052D0002/00A004 Flanders 779 m² 1 · 182 m² 10.6 m · 2 fl.
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Similar companies · same sector, comparable size

Of 16,623 companies in sector 86220 we hold annual accounts for 7,972. 6,727 are within a factor 10 of this equity.See the whole sector

Company data · Crossroads Bank

Identification
Legal formPrivate limited company
Founded16-12-2013
Fiscal year end31-12
Activities, NACEBEL
86220Specialist medical practice
Sources
Crossroads Bank for EnterprisesNational Bank · 12 filingsAddress and cadastre registers

Data from official sources, last processed on 16-09-2026. Scores and ratios are computed by Checked and are not a credit decision.